Strains of bifidobacterium having the ability to produce glutamine
AssigneeProbi AB
InventorsGoran Molin, Siv Ahrne, Bengt Jeppsson
Life of this patent
Estimating the term…
Abstract
The invention refers to new strains of Bifidobacterium, especially of the species Bifidobacterium infantis, having the ability to survive in the intestinal tract and to produce glutamine and optionally arginine in vivo, as well as to compositions comprising said strains.
Claims3
A biologically pure culture of a strain of Bifidobacterium infantis selected from the group consisting of Bifidobacterium infantis CURE 19, DSM 15158, Bifidobacterium infantis CURE 21, DSM 15159, Bifidobacterium infantis CURE 26, DSM 15160, Bifidobacterium infantis CURE 28, DSM 15161, and Bifidobacterium infantis CURE 29, DSM 15162, wherein said strain survives in the intestinal tract of a human being and produces glutamine in vivo.
Dependencies are inferred from the claim text.